Friday 27th June 2025 13:00 - 14:00 (BST)
Gene therapy has long been heralded as a game-changer in rare disease treatment, yet the path from scientific breakthrough to real-world impact remains complex. The field has seen remarkable advancements, including ‘non-rare’ diseases, while challenges in access, affordability, regulation, and clinical implementation persist.
This 60-minute masterclass will examine whether gene therapy is meeting expectations or if hurdles such as high costs, limited patient access, and uncertain long-term outcomes are slowing progress.
Our expert panel will discuss how the Life Sciences industry, healthcare systems, and policymakers must adapt to make gene therapies a viable reality.

27th Jun 2025 13:00 – 14:00 (BST)
Speakers
Experienced Board member | Chief Executive of Gene People | Interim CEO & Consultant
Managing Director at Oxygen Strategy
Principal at OMGEN | NED | General Manager
Global Vice President of Market Access AscellaHealth
Director at NJ Redfern Ltd
Are you ready to transform your skills and unlock your full potential? Now is the time to elevate your training.
Join Now